Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer

Table 2 Relationship between hemoglobin, albumin, lymphocyte, and platelet and clinical features in patients with resected pancreatic cancer

Features	HALP
	Low (≤ 44.56, n = 231)	High (> 44.56, n = 351)	P value
Age (yr)			0.161
≤ 62	112	191
> 62	119	160
Gender			0.005
Female	121	142
Male	110	209
Preoperative CA19-9			0.473
≤ 37 U/mL	60	82
> 37 U/mL	171	269
NLR			< 0.001
≤ 2.20	77	218
> 2.20	154	133
PLR			< 0.001
≤ 112.94	17	234
> 112.94	214	117
PNI			< 0.001
≤ 53.10	187	146
> 53.10	44	205
Tumor location			< 0.001
Head	122	121
Body/Tail	109	230
TNM stage			0.008
IA	13	26
IB	59	105
IIA	30	64
IIB	86	124
III	43	32
Tumor size			0.718
≤ 4.0 cm	146	227
> 4.0 cm	85	124
Lymph node metastasis			0.002
0	102	195
1-3	86	124
> 3	43	32
Tumor differentiation			0.032
Well/Moderate	131	230
Poor	100	121
Neural invasion			0.672
No	44	62
Yes	187	289
Microvascular invasion			1.000
No	173	283
Yes	58	68

HALP: Hemoglobin, albumin, lymphocyte, and platelet; NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; PNI: Prognostic nutritional index.